Previous reports demonstrated that β-arrestin2 negatively regulates the activity of NF-κB by modulating IκBα degradation [8], [9], lipopolysaccharide-induced endotoxin shock [10], and sepsis-induced inflammation [12]. This evidence concerns the gene NFKBIA and Sepsis.